SubHero Banner

Imodium® (loperamide) – Safety communication

January 30, 2018 - The FDA announced that they are limiting the number of doses per package for over-the-counter (OTC) loperamide products due to reports of serious heart problems and deaths with higher than recommended doses, primarily in individuals who are intentionally misusing or abusing the product.

Download PDF